MAMATA MACHINERY: Q3 EBITDA 84.3M RUPEES VS 127.2M (YOY) || Q3 EBITDA MARGIN 12.55% VS 17.33% (YOY)

MAMATA MACHINERY: Q3 REVENUE 672M RUPEES VS 734M (YOY)

MAMATA MACHINERY: Q3 CONS NET PROFIT 78.6M RUPEES VS 88M (YOY)

NITIN SPINNERS: Q3 EBITDA 1.11B RUPEES VS 1.17B (YOY) || Q3 EBITDA MARGIN 13.93% VS 13.96% (YOY)

NITIN SPINNERS: Q3 REVENUE 8B RUPEES VS 8.4B (YOY)

NITIN SPINNERS: Q3 SL NET PROFIT 444M RUPEES VS 448M (YOY)

BHARAT DYNAMICS: Q3 EBITDA 260M RUPEES VS 1.3B (YOY) || Q3 EBITDA MARGIN 4.59% VS 15.30% (YOY)

BHARAT DYNAMICS: Q3 REVENUE 5.6B RUPEES VS 8.3B (YOY)

BHARAT DYNAMICS: Q3 SL NET PROFIT 729.2M RUPEES VS 1.5B (YOY)

BIRLA CORPORATION: Q3 EBITDA 21.5B RUPEES VS 22.5B (YOY) || Q3 EBITDA MARGIN 13.55% VS 10.99% (YOY)

BIRLA CORPORATION: Q3 REVENUE 21.5B RUPEES VS 22.6B (YOY)

BIRLA CORPORATION: Q3 CONS NET PROFIT 527.6M RUPEES VS 312M (YOY)

SUN PHARMACEUTICAL INDUSTRIES: Q3 EBITDA 49.4B RUPEES VS 40.08B (YOY) || Q3 EBITDA MARGIN 32% VS 29.30% (YOY)

SUN PHARMACEUTICAL INDUSTRIES: Q3 REVENUE 155.2B RUPEES VS 136.7B (YOY)

SUN PHARMACEUTICAL INDUSTRIES: Q3 CONS NET PROFIT 33.6B RUPEES VS 29B (YOY)

MEGHMANI ORGANICS: Q3 EBITDA 377M RUPEES VS 408M (YOY) || Q3 EBITDA MARGIN 7.42% VS 7.18% (YOY)

MEGHMANI ORGANICS: Q3 REVENUE 5.08B RUPEES VS 5.7B (YOY)